Lunit will highlight four oral presentations and three poster presentations at ECR 2024, ranging from adaptability in different use cases to the potential to act as an independent reader in mammography double-reading settings.
Oral presentations featuring Lunit INSIGHT at ECR 2024 include the following:
- “The performance of a commercial artificial intelligence algorithm in an external quality assurance scheme regularly used by humans in the NHS breast screening programme” (ACV 2024 Research Stage 2, February 28, 3 p.m. to 4 p.m.)
- “The Multi- Sixteen Thousand and Counting: Performance of an Artificial Intelligence Tool for Identifying Common Pathologies on Chest Radiographs and Report Prioritisation” (ACV 2024 Research Stage 1, February 29, 2 p.m. to 3:30 p.m.)
- “Recent development in AI for lung nodule detection” (ACV 2024 Research Stage 2, March 1, 8 a.m. to 9 a.m.)
- “Integration of artificial intelligence (AI) in double-read population-based mammography screening: simulated replacement of one reader and beyond” (ACV 2024 Research Stage 1, March 3, 11:30 a.m. to 12:30 p.m.)
Poster presentations meanwhile include:
- “Can artificial intelligence decrease the time to histological diagnosis of lung cancer - a retrospective-cohort study” (EPOS Area -2 Level)
- “Deep Learning for Chest Radiograph Evaluation in Children: Repurposed Use of a Commercially Available AI Tool Developed for Adults (EPOS Area -2 Level)
- “Comparison of three AI breast density tools with a human reader” (EPOS Area -2 Level)
Lunit will also be stationed at booth AI-15 in the EXPO X1 hall, where it will further showcase its INSIGHT suite for radiology.
